BridgeBio Oncology Therapeutics

BBOT · NASDAQ

$2.72−$0.13 (−4.56%)TodayMarket closed ·
Prev close $2.85

Who owns BBOT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 73.3% of BBOT’s shares.

  • Cormorant Asset Management, LP22.3%
  • BridgeBio Pharma, Inc.18.2%
  • Deerfield Management Company, L.P.6.1%
  • BC Global Opportunities IX LP5.4%
  • Next 6 largest institutions21.2%
  • All other shareholders26.7%
Top institutional holders of BBOT
HolderShares% of shares
Cormorant Asset Management, LP17.88M22.32%
BridgeBio Pharma, Inc.14.59M18.21%
Deerfield Management Company, L.P.4.89M6.10%
BC Global Opportunities IX LP4.37M5.45%
Omega Fund Management, LLC3.29M4.11%
Alphabet, Inc.2.82M3.52%
EcoR1 Capital, LLC2.82M3.52%
Wellington Management Company, LLP2.79M3.48%
Enavate Sciences GP, LLC2.63M3.28%
Citadel Advisors LLC2.62M3.27%

Largest mutual fund holders

Top mutual fund holders of BBOT
HolderShares% of shares
Vanguard Total Stock Market Index Fund1.42M1.78%
State Street SPDR S&P Biotech ETF858.20K1.07%
BlackRock Health Sciences Opportunities Portfolio673.77K0.84%
Vanguard Extended Market Index Fund550.63K0.69%
iShares Biotechnology ETF320.74K0.40%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of BBOT in the last 6 months.

Latest BBOT insider transactions
InsiderTypeSharesValue
Elmelech IdanTax withholding343$1.35K
Beltran PedroTax withholding1.05K$4.13K
Ben YongTax withholding1.05K$4.13K
Cobo MarcTax withholding126$496
Cobo MarcAward43.70K—
Cobo MarcTax withholding203$1.12K
Cobo MarcAward9.04K—
Elmelech IdanTax withholding343$2.68K
Ben YongTax withholding1.05K$8.17K
Beltran PedroTax withholding1.05K$8.17K

Short interest

Settled Sep 30, 2026

Shares short
3.37M
Days to cover
5.40
% of shares outstanding
4.21%
Average daily volume
624.66K
Change since last report
−6.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.